Publications
Nightingale’s technology is routinely used in world-class epidemiological and genetic studies. There are over 450 publications that have utilized our technology. If you are interested in using our technology for medical research, visit our website for researchers here.
All
Ageing
Bioinformatics
Cancer
Cardiovascular diseases
Drug development
Fatty liver disease
Gut microbiota
Human genetics
Kidney disease
Maternal health
Metabolic risk factors
Method description
Neurological diseases
Nutrition
T1D
T2D
Schutte et al. Am J Clin Nutr. 2022 Jan 31:nqac025
Macdonald-Dunlop et al. Aging (Albany NY). 2022. Jan 2414:623-659
Metabolic risk factors
Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment
Rendeiro et al. Frontiers in Immunology, Vol12, 2022
Metabolic risk factors
Decreasing severity of obesity from early to late adolescence and young adulthood associates with longitudinal metabolomic changes implicated in lower cardiometabolic disease risk
Mansell et al. In J Obes (Lond). 2022. Mar;46(3):646-654
Neurological diseases
Profiling the metabolome of patients with dementia in the UK Biobank
Liu et al. Alzheimer's Dement., 17: e056147
Human genetics
Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism
Li-Gao et al. Diabetes. 2021 Dec;70(12):2932-2946
Cardiovascular diseases
Metabolomics Defines Complex Patterns of Dyslipidaemia in Juvenile-SLE Patients Associated with Inflammation and Potential Cardiovascular Disease Risk
Robinson et al. Metabolites 2019
Human genetics
1H-NMR metabolomics-based surrogates to impute common clinical risk factors and endpoints.
Bizzarri, D. et al. eBioMedicine, Volume 75, 103764
Fatty liver disease
Adiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study
Pang et al. Am J Clin Nutr. 2022 Mar 4;115(3):799-810
Metabolic risk factors
Metabolic Biomarkers for Peripheral Artery Disease Compared with Coronary Artery Disease: Lipoprotein and metabolite profiling of 31,657 individuals from five prospective cohorts
Tikkanen et al. JAHA 2021 ;10(23):e021995
Metabolic risk factors
Circulating Metabolites and the Development of Type 2 Diabetes in Chinese Adults
Bragg et al. Diabetes Care Feb 1;45(2):477-480.
Fung et al. The Lancet Healthy Longevity, Volume 2, Issue 11, e724 - e735
Metabolic risk factors
Mendelian randomization identifies the potential causal impact of dietary patterns on circulating blood metabolites
Taba et al. Front Genet. 2021 ;12:738265
Fatty liver disease
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
Luukkonen et al. J Hepatol. 2022 Mar;76(3):526-535
Metabolic risk factors
Fat metabolism is associated with telomere length in six population-based studies
Van der Spec et al. Hum Mol Genet. 2022 Mar 31;31(7):1159-1170